Finasteride
This medicine is intended for use only in men.
Finasteride, the active substance of Zasterid, is a 5-alpha reductase inhibitor, an enzyme that converts testosterone (male sex hormone) into a more potent dihydrotestosterone (DHT). Zasterid reduces the size of the prostate gland.
Zasterid is used to treat a condition called benign prostatic hyperplasia. The prostate gland, located in the area of the urinary bladder, has enlarged, causing difficulties in urinating. Zasterid is indicated for the treatment of benign prostatic hyperplasia to:
If your sexual partner is pregnant or may be pregnant, you should avoid exposing her to your semen, which may contain small amounts of the medicine.
Zasterid is not indicated for use in women.
Before starting to take Zasterid, discuss it with your doctor or pharmacist.
Tell your doctor about all your current or past illnesses and allergies.
Benign prostatic hyperplasia is a condition that develops over many years. In some patients, relief of symptoms occurs soon after starting treatment. However, it may be necessary to take the medicine for at least 6 months to achieve significant improvement.
Regardless of whether symptoms improve, taking Zasterid may reduce the risk of acute urinary retention and the need for surgical treatment.
To monitor the progress of treatment, you should remain under regular medical supervision.
Benign prostatic hyperplasia is not a tumor, nor does it lead to the development of a tumor, but these conditions can occur together. Only a doctor can properly assess the symptoms and their likely cause.
Taking Zasterid may affect the results of the PSA (prostate-specific antigen) test. Therefore, before undergoing this test, tell your doctor that you are taking Zasterid. Zasterid is indicated only for men for the treatment of benign prostatic hyperplasia.
Patients taking Zasterid have reported mood changes, such as depressive mood and depression, and less frequently, suicidal thoughts. If you experience any of these symptoms, you should immediately consult your doctor for further medical advice.
Zasterid is not indicated for use in children.
Tell your doctor or pharmacist about all the medicines you are taking or have recently taken, as well as any medicines you plan to take. Zasterid usually does not affect the action of other medicines taken.
Pregnant women and women of childbearing age must not take Zasterid. They should also not touch crushed or broken Zasterid tablets. If the active substance of Zasterid enters the body (after oral administration or through skin contact) of a pregnant woman carrying a male fetus, it may cause developmental disorders of the genital organs in the fetus. If a pregnant woman comes into contact with the active substance of Zasterid, she should inform her doctor. Zasterid tablets are film-coated, which prevents direct contact with the active substance, provided that the tablets are not damaged or crushed.
Your doctor can provide more information on this.
It is not known whether finasteride passes into human milk.
Available data indicate that Zasterid does not affect the ability to drive or use machines.
The medicine contains 102.63 mg of lactose in one tablet. If you have previously been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The recommended dose is one 5 mg tablet per day, taken regardless of meals.
The medicine should be taken orally.
Remember that benign prostatic hyperplasia is a process that takes many years before symptoms appear. Zasterid may relieve symptoms and allow control of the disease if taken regularly for a long time.
No dose adjustment is required in patients with renal impairment of any degree and/or hepatic impairment.
No dose adjustment is necessary in elderly patients.
If you have taken more than the recommended dose of Zasterid, contact your doctor or pharmacist immediately.
Take Zasterid as directed by your doctor. However, if you miss a dose, do not take an extra tablet. The next day, return to the dosing schedule prescribed by your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Zasterid can cause side effects, although not everybody gets them.
swelling of the face, tongue, or throat, difficulty swallowing, breathing difficulties, and hives.
Common(may affect up to 1 in 10 people):
In some cases, these symptoms may resolve during treatment. However, if side effects persist, you should consult your doctor, who may decide to stop Zasterid treatment.
Uncommon(may affect up to 1 in 100 people):
Frequency not known(frequency cannot be estimated from the available data)
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C
02-222 Warsaw
tel.: 22 49-21-301
fax: 22 49-21-309
e-mail: ndl@urpl.gov.pl.
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store in the original package to protect from light.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the label after EXP. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Tablet core: magnesium stearate, talc, starch, microcrystalline cellulose, sodium carboxymethyl cellulose (type A), lactose monohydrate (102.25 mg).
Coating: titanium dioxide (E171), lactose monohydrate (0.3809 mg), macrogol 6000, hydroxypropyl cellulose, hypromellose.
White or almost white, slightly convex, film-coated tablets in the shape of a triangle with rounded edges, with the inscription "RG" on one side.
28 film-coated tablets
Gedeon Richter Plc.
Gyömrői út 19-21
1103 Budapest
Hungary
For more information about this medicine, contact:
GEDEON RICHTER POLSKA Sp. z o.o.
Medical Department
ul. ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
Tel. +48 (22)755 96 48
lekalert@grodzisk.rgnet.org
fax: +48 (22) 755 96 24
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.